Tumor markers in ovarian malignancies

Oncologist

Volumn 2, Issue 5, 1997, Pages 324-329

  Eagle, Karen ^a   Ledermann, Jonathan A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CA125; Ovarian cancer; Tumor markers

Indexed keywords

CA 125 ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER RECURRENCE; CANCER SCREENING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; OVARY CANCER; PELVIS CANCER; PRIORITY JOURNAL; RELAPSE;

EID: 0030724158     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-5-324     Document Type: Article

References (12)

1. Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumour markers to detect disease. (Review). Am J Obstet Gynecol 1994;170:1099-1107.
2. Bast RC, Feeney M, Lazarus H et al. Reactivity of a monoclonal antibody with a human ovarian carcinoma. J Clin Invest 1981;68:1311-1337.
3. Bast RC, Klug TL, St. John E et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-887.
4. Zurawski R, Orjaster H, Andersen A et al. Elevated serum CA125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int J Cancer 1988;42:677-680.
5. Jacobs I, Bast RC. The CA125 tumour-associated antigen: a review of the literature. Hum Reprod 1989;4:1-12.
6. Vasilev SA, Schaerth JB, Campeau J et al. Serum CA125 levels in preoperative evaluation of pelvic masses. Obstet Gynecol 1988;71:751-756.
7. Malkasian GD, Knapp R, Lavin P et al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341-346.
8. Jacobs I, Bridges J, Reynolds C et al. Multimodal approach to screening for ovarian cancer. Lancet 1988;1:268-271.
9. Jacobs I, Prys Davies A, Bridges J et al. Prevalence screening for ovarian cancer in postmenopausal women by CA125 measurement and ultrasonography. BMJ 1993;306:1030-1034.
10. Einhorn N, Knapp R, Zurawski V. CA125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary. Acta Oncol 1989;28:655-657.
11. Soper JT, Hunter V, Daly L et al. Pre-operative serum tumour associated antigen levels in women with pelvic masses. Gynecol Oncol 1990;75:249-254.
12. Woolas RP, Xu FJ, Jacobs IJ et al. Elevation of multiple serum markers in stage I ovarian cancer. J Natl Cancer Inst 1993;85:1748-1751.